Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1]
Identifieur interne : 000153 ( Main/Exploration ); précédent : 000152; suivant : 000154Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1]
Auteurs : RBID : ISTEX:259_1994_Article_BF02426702.pdfDOI: 10.1007/BF02426702
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title>Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1]</title>
<author><name>Lorenzo Maffioli</name>
<affiliation wicri:level="1"><mods:affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan</wicri:regionArea>
<wicri:noRegion>Milan</wicri:noRegion>
</affiliation>
</author>
<author><name>Arturo Chiti</name>
<affiliation wicri:level="1"><mods:affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan</wicri:regionArea>
<wicri:noRegion>Milan</wicri:noRegion>
</affiliation>
</author>
<author><name>Massimo Gasparini</name>
<affiliation wicri:level="1"><mods:affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan</wicri:regionArea>
<wicri:noRegion>Milan</wicri:noRegion>
</affiliation>
</author>
<author><name>Emilio Bombardieri</name>
<affiliation wicri:level="1"><mods:affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan</wicri:regionArea>
<wicri:noRegion>Milan</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="RBID">ISTEX:259_1994_Article_BF02426702.pdf</idno>
<date when="1994">1994</date>
<idno type="doi">10.1007/BF02426702</idno>
<idno type="wicri:Area/Main/Corpus">000987</idno>
<idno type="wicri:Area/Main/Curation">000987</idno>
<idno type="wicri:Area/Main/Exploration">000153</idno>
</publicationStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<mods xsi:schemaLocation="http://www.loc.gov/mods/v3 file:///applis/istex/home/loadistex/home/etc/xsd/mods.xsd" version="3.4" istexId="ac980eff685397d459cdadf778b5ddd7ec8431fc"><titleInfo lang="eng"><title>Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1]</title>
</titleInfo>
<name type="personal"><namePart type="given">Lorenzo</namePart>
<namePart type="family">Maffioli</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
<affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</affiliation>
</name>
<name type="personal"><namePart type="given">Arturo</namePart>
<namePart type="family">Chiti</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
<affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</affiliation>
</name>
<name type="personal"><namePart type="given">Massimo</namePart>
<namePart type="family">Gasparini</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
<affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</affiliation>
</name>
<name type="personal"><namePart type="given">Emilio</namePart>
<namePart type="family">Bombardieri</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
<affiliation>National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy</affiliation>
</name>
<typeOfResource>text</typeOfResource>
<genre>Letters to the Editor</genre>
<originInfo><publisher>Springer-Verlag, Berlin/Heidelberg</publisher>
<dateValid encoding="w3cdtf">2006-05-05</dateValid>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
</physicalDescription>
<relatedItem type="series"><titleInfo type="abbreviated"><title>Eur J Nucl Med</title>
</titleInfo>
<titleInfo><title>European Journal of Nuclear Medicine</title>
<partNumber>Year: 1994</partNumber>
<partNumber>Volume: 21</partNumber>
<partNumber>Number: 12</partNumber>
</titleInfo>
<genre>Archive Journal</genre>
<originInfo><dateIssued encoding="w3cdtf">1994-12-01</dateIssued>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<subject usage="primary"><topic>Medicine & Public Health</topic>
<topic>Imaging / Radiology</topic>
<topic>Nuclear Medicine</topic>
<topic>Cardiology</topic>
<topic>Oncology</topic>
<topic>Orthopedics</topic>
</subject>
<identifier type="issn">0340-6997</identifier>
<identifier type="issn">Electronic: 1619-7089</identifier>
<identifier type="matrixNumber">259</identifier>
<identifier type="local">IssueArticleCount: 19</identifier>
<recordInfo><recordOrigin>Springer-Verlag, 1994</recordOrigin>
</recordInfo>
</relatedItem>
<identifier type="doi">10.1007/BF02426702</identifier>
<identifier type="matrixNumber">Art15</identifier>
<identifier type="local">BF02426702</identifier>
<accessCondition type="use and reproduction">MetadataGrant: OpenAccess</accessCondition>
<accessCondition type="use and reproduction">AbstractGrant: OpenAccess</accessCondition>
<accessCondition type="restriction on access">BodyPDFGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BodyHTMLGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BibliographyGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">ESMGrant: Restricted</accessCondition>
<part><extent unit="pages"><start>1366</start>
<end>1366</end>
</extent>
</part>
<recordInfo><recordOrigin>Springer-Verlag, 1994</recordOrigin>
<recordIdentifier>259_1994_Article_BF02426702.pdf</recordIdentifier>
</recordInfo>
</mods>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000153 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000153 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= *** parameter Area/wikiCode missing *** |area= IndiumV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:259_1994_Article_BF02426702.pdf |texte= Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1] }}
This area was generated with Dilib version V0.5.81. |